Silvia Vivarelli Selected Research

Silvia Vivarelli Research Topics

12	Neoplasms (Cancer) 04/2023 - 01/2019
3	Parkinson Disease (Parkinson's Disease) 09/2021 - 12/2017
2	Neuroinflammatory Diseases 01/2018 - 12/2017
1	Infertility (Sterility) 05/2024
1	Lung Neoplasms (Lung Cancer) 04/2023
1	Clostridium Infections 01/2023
1	Chronic Disease (Chronic Diseases) 01/2023
1	Diarrhea 01/2023
1	Inflammation (Inflammations) 01/2023
1	Melanoma (Melanoma, Malignant) 01/2023
1	Neoplasm Metastasis (Metastasis) 01/2023
1	Mucositis 01/2023
1	Hematologic Neoplasms (Hematological Malignancy) 10/2021
1	Virus Diseases (Viral Diseases) 01/2021
1	Lymphoma (Lymphomas) 09/2020
1	Infections 08/2020
1	COVID-19 08/2020
1	Severe Acute Respiratory Syndrome 08/2020
1	Neurodegenerative Diseases (Neurodegenerative Disease) 01/2020
1	Glioblastoma (Glioblastoma Multiforme) 09/2019
1	Alzheimer Disease (Alzheimer's Disease) 09/2019
1	Carcinogenesis 01/2019
1	Dysbiosis 01/2019

4	Immune Checkpoint InhibitorsIBA 04/2023 - 08/2020
3	Transcription Factors (Transcription Factor)IBA 02/2022 - 09/2020
3	Biomarkers (Surrogate Marker)IBA 09/2021 - 08/2021
3	MicroRNAs (MicroRNA)IBA 09/2019 - 12/2017
1	RNA (Ribonucleic Acid)IBA 05/2024
1	TensinsIBA 01/2023
1	Irinotecan (Camptosar)FDA LinkGeneric 01/2023
1	Anti-Bacterial Agents (Antibiotics)IBA 01/2023
1	AntioxidantsIBA 01/2023
1	EnzymesIBA 01/2023
1	Fluorouracil (Carac)FDA LinkGeneric 01/2023
1	Phosphoric Monoester Hydrolases (Phosphatases)IBA 01/2023
1	NF-kappa B (NF-kB)IBA 01/2023
1	Cytoplasmic and Nuclear Receptors (Nuclear Receptors)IBA 01/2023
1	Mitogen-Activated Protein KinasesIBA 01/2023
1	Phosphatidylethanolamine Binding ProteinIBA 01/2023
1	Phosphatidylinositol 3-Kinase (1 Phosphatidylinositol 3 Kinase)IBA 01/2023
1	PolyphenolsIBA 01/2023
1	Nitric Oxide Synthase Type II (Inducible Nitric Oxide Synthase)IBA 06/2022
1	Proteins (Proteins, Gene)FDA Link 02/2022
1	raf KinasesIBA 02/2022
1	Nitric Oxide (Nitrogen Monoxide)FDA Link 10/2021
1	Nitric Oxide Synthase (NO Synthase)IBA 10/2021
1	AntibodiesIBA 01/2021
1	SurvivinIBA 09/2020
1	diazonaphthalenedisulfonic acid (NDS)IBA 01/2020
1	alpha-SynucleinIBA 12/2017

7	Therapeutics 04/2023 - 01/2019
3	Immunotherapy 01/2023 - 01/2019
3	Drug Therapy (Chemotherapy) 01/2023 - 01/2019
2	Radiotherapy 01/2023 - 01/2019
1	Critical Care (Surgical Intensive Care) 08/2020